The Korea University Medical Center is a collection of several hospitals, as well as the College of Medicine and College of Nursing associated with Korea University in Seoul, South Korea.

During the past decade, Korea university anam hospital conducted 315 clinical trials. In the 10-year time frame, 315 clinical trials started and 88 clinical trials were completed, i.e. on average, 27.9% percent of trials that started reached the finish line to date. In the past 5 years, 154 clinical trials started and 66 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Korea university anam hospital" #1 sponsor was "Korea University Anam Hospital" with 41 trials, followed by "Hoffmann-La Roche" with 22 trials sponsored, "Chong Kun Dang Pharmaceutical" with 21 trials sponsored, "Pfizer" with 21 trials sponsored and "Seung-Jung Park" with 21 trials sponsored. Other sponsors include 319 different institutions and companies that sponsored additional 165 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Korea university anam hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 18 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 13 trials as a collaborator, "Korea University Anam Hospital" with 10 trials as a collaborator, "AstraZeneca" with 6 trials as a collaborator and "Asan Medical Center" with 5 trials as a collaborator. Other collaborators include 186 different institutions and companies that were collaborators in the rest 135 trials.

According to Clinical.Site data, the most researched conditions in "Korea university anam hospital" are "Breast Cancer" (18 trials), "Coronary Artery Disease" (18 trials), "Atrial Fibrillation" (16 trials), "Healthy" (14 trials) and "Gastric Cancer" (12 trials). Many other conditions were trialed in "Korea university anam hospital" in a lesser frequency.

Most popular intervention types in "Korea university anam hospital" are "Drug" (333 trials), "Device" (48 trials), "Procedure" (32 trials), "Biological" (28 trials) and "Other" (26 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (70 trials), "Cisplatin" (12 trials), "Carboplatin" (10 trials), "Paclitaxel" (10 trials) and "Gemcitabine" (9 trials). Other intervention names were less common.

The vast majority of trials in "Korea university anam hospital" are 391 trials for "All" genders, 33 trials for "Male" genders and 20 trials for "Female" genders.

Currently, there are NaN active trials in "Korea university anam hospital". 2 are not yet recruiting, 88 are recruiting, 58 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 214 completed trials in Korea university anam hospital, undefined suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Korea university anam hospital, 57 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 153 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 59 trials, and there were also 52 trials that are defined as “Not Applicable".